Oncolytics Biotech (ONC) Competitors C$0.55 -0.01 (-1.79%) As of 05/23/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock ONC vs. BCT, IPA, TH, SCYB, COM, APS, NVH, IGX, MDNA, and COVShould you be buying Oncolytics Biotech stock or one of its competitors? The main competitors of Oncolytics Biotech include BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Theratechnologies (TH), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Aptose Biosciences (APS), Novoheart (NVH), IntelGenx Technologies (IGX), Medicenna Therapeutics (MDNA), and Covalon Technologies (COV). These companies are all part of the "biotechnology" industry. Oncolytics Biotech vs. BriaCell Therapeutics ImmunoPrecise Antibodies Theratechnologies Scythian Biosciences 138267 (COM.TO) Aptose Biosciences Novoheart IntelGenx Technologies Medicenna Therapeutics Covalon Technologies BriaCell Therapeutics (CVE:BCT) and Oncolytics Biotech (TSE:ONC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, community ranking, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations. Do insiders & institutionals have more ownership in BCT or ONC? 1.8% of Oncolytics Biotech shares are owned by institutional investors. 3.8% of Oncolytics Biotech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has better valuation and earnings, BCT or ONC? BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Oncolytics Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBriaCell TherapeuticsN/AN/AN/A-C$0.38-28.19Oncolytics BiotechN/AN/A-C$27.66M-C$0.36-1.53 Does the media refer more to BCT or ONC? In the previous week, Oncolytics Biotech had 8 more articles in the media than BriaCell Therapeutics. MarketBeat recorded 8 mentions for Oncolytics Biotech and 0 mentions for BriaCell Therapeutics. BriaCell Therapeutics' average media sentiment score of 0.00 beat Oncolytics Biotech's score of -1.13 indicating that BriaCell Therapeutics is being referred to more favorably in the media. Company Overall Sentiment BriaCell Therapeutics Neutral Oncolytics Biotech Negative Does the MarketBeat Community believe in BCT or ONC? Oncolytics Biotech received 156 more outperform votes than BriaCell Therapeutics when rated by MarketBeat users. Likewise, 74.52% of users gave Oncolytics Biotech an outperform vote while only 68.97% of users gave BriaCell Therapeutics an outperform vote. CompanyUnderperformOutperformBriaCell TherapeuticsOutperform Votes4068.97% Underperform Votes1831.03% Oncolytics BiotechOutperform Votes19674.52% Underperform Votes6725.48% Is BCT or ONC more profitable? BriaCell Therapeutics' return on equity of 0.00% beat Oncolytics Biotech's return on equity.Company Net Margins Return on Equity Return on Assets BriaCell TherapeuticsN/A N/A N/A Oncolytics Biotech N/A -141.94%-71.33% Do analysts recommend BCT or ONC? BriaCell Therapeutics presently has a consensus price target of C$15.00, suggesting a potential upside of 41.51%. Oncolytics Biotech has a consensus price target of C$3.50, suggesting a potential upside of 536.36%. Given Oncolytics Biotech's stronger consensus rating and higher possible upside, analysts clearly believe Oncolytics Biotech is more favorable than BriaCell Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BriaCell Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Oncolytics Biotech 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryOncolytics Biotech beats BriaCell Therapeutics on 9 of the 12 factors compared between the two stocks. Get Oncolytics Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart ONC vs. The Competition Export to ExcelMetricOncolytics BiotechBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$42.39MC$128.94MC$5.33BC$5.94BDividend Yield0.31%3.74%5.27%6.32%P/E Ratio-1.533.4526.8329.42Price / SalesN/A4,168.74396.30926.00Price / Cash4.2213.1938.3283.58Price / Book4.6833.216.764.01Net Income-C$27.66M-C$91.56MC$3.24BC$300.67M7 Day Performance-15.38%2.79%0.31%0.99%1 Month Performance-32.10%6.81%6.62%5.65%1 Year Performance-63.09%102.22%18.47%16.86% Oncolytics Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONCOncolytics Biotech0.6583 of 5 starsC$0.55-1.8%C$3.50+536.4%-62.1%C$42.39MN/A-1.5329News CoverageNegative NewsAnalyst RevisionHigh Trading VolumeBCTBriaCell TherapeuticsN/AC$10.60-3.8%C$15.00+41.5%+0.0%C$168.68MN/A-28.195IPAImmunoPrecise AntibodiesN/AC$6.50+0.8%N/A+0.0%C$162.08MC$19.47M-7.3080Gap DownTHTheratechnologiesN/AC$3.61-0.8%N/A+113.5%C$115.18MC$52.22M-40.86103SCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/AN/AC$102.19MN/A0.00N/AAPSAptose BiosciencesN/AC$2.37+0.4%N/A-94.6%C$102.05MN/A-0.4731Gap UpNVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423,500.00-13.95N/AIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap UpMDNAMedicenna TherapeuticsN/AC$1.14+0.9%N/A-55.6%C$85.29MC$4,868.39-3.1420COVCovalon TechnologiesN/AC$2.80+6.1%N/A+145.5%C$76.72MC$27.87M32.14N/AGap Up Related Companies and Tools Related Companies BriaCell Therapeutics Alternatives ImmunoPrecise Antibodies Alternatives Theratechnologies Alternatives Scythian Biosciences Alternatives 138267 (COM.TO) Alternatives Aptose Biosciences Alternatives Novoheart Alternatives IntelGenx Technologies Alternatives Medicenna Therapeutics Alternatives Covalon Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:ONC) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersMarket chaos is the new normalIt happened again. Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, lapto...Augusta Precious Metals | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored52 Money Mondays for $7 (This Weekend Only)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncolytics Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncolytics Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ONC Stock Free ONC Stock Alerts